Health Trials

Systemic Anaplastic Large-Cell Lymphoma

1

Review clinical trials related to Systemic Anaplastic Large-Cell Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas (FHTCLs), or systemic anaplastic large-cell lymphoma (sALCL).

Participants needed: 150
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Corvus Pharmaceuticals, Inc.Updated: Apr 8, 2026Locations: 34
Eligibility criteria

Adult participants ≥18 years of age on the day of signing the informed consent f... [+19]

Participants who have T-cell lymphoma with active central nervous system involve... [+17]

Read more